Pulmonx Corporation logo

LUNGPulmonx Corporation

LUNG Stock Price, Valuation & Chart | Pulmonx Corporation

Compare

LUNG Historical price chart

LUNG Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization96.30M
PE Ratio-1.97
EPS-1.16
Trading Volume407.39K
Today's High/Low2.44/2.28
Dividend Yield0.00
52 Week High/Low2.89/1.13
Shares Outstanding42.24M
LUNG Financial Statement
LUNG Analyst ratings
LUNG Analysis & performance metrics

LUNG Company profile

Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr…

LUNG Management team

Management
Sarah Huber
Vice President of Sales (U.S.)
David A. Lehman J.D.
General Counsel & Secretary
Glendon E. FrenchCEO
Chief Executive Officer, President & Director
Steven S. Williamson
Advisor
Derrick Sung Ph.D.CFO
Chief Financial Officer & Chief Operating Officer
Sri Radhakrishnan
Chief Technical Officer
Marcee M. Maroney
Vice President of Marketing
Lisa Paul
Chief People Officer
Total 8 executives

LUNG Frequently asked questions

What is Pulmonx Corporation (LUNG) Stock Price?

Current stock price of Pulmonx Corporation (LUNG) stock is $2.280. The stock price is +1.79% higher in the session. The intraday range can be seen from this page. Volume of Pulmonx Corporation (LUNG) stock is 407.39K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Pulmonx Corporation (LUNG) stock price going up or down today?

The stock price of Pulmonx Corporation (LUNG) can change with earnings, company news, and overall market sentiment. Pulmonx Corporation operates in the Healthcare / Medical - Devices market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Pulmonx Corporation stock expensive at its current price?

Whether Pulmonx Corporation looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for LUNG on this page is -1.97. EPS on this page is -1.16. Compare those figures with peers and growth expectations before deciding if the current Pulmonx Corporation price is justified.

How has the stock price of Pulmonx Corporation (LUNG) performed historically?

Historical performance for Pulmonx Corporation (LUNG) is shown on the price chart on this page. Review multi-period moves alongside volume to see how LUNG reacted to past earnings and market events.

Should I buy Pulmonx Corporation (LUNG) stock, at this price?

Buying Pulmonx Corporation (LUNG) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.